Search research articles
Contact Us
Filters
Showing results (1581-1590 of 1,594) with videos related to
Page
of 160
Sort By:
Cancer Medicine
|
July 12, 2019
Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms
Yu Zhang, Liang Shang, Pan-Pan Zhang, et al.
Journal of Medicinal Chemistry
|
April 8, 2021
Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous <i>MTAP</i> Deletion
Zenon Konteatis, Jeremy Travins, Stefan Gross, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma
Zenon Konteatis, Erin Artin, Brandon Nicolay, et al.
Annals of Human Genetics
|
March 2, 2019
Significant association of rare variant p.Gly8Ser in cardiac sodium channel β4-subunit SCN4B with atrial fibrillation
Hongbo Xiong, Qin Yang, Xiaoping Zhang, et al.
Chemistry & Biology
|
September 25, 2012
Small molecule activation of PKM2 in cancer cells induces serine auxotrophy
Charles Kung, Jeff Hixon, Sung Choe, et al.
Plant Disease
|
November 26, 2022
Translocation of Fungicides and Their Efficacy in Controlling <i>Phellinus noxius</i>, the Cause of Brown Root Rot Disease
Ting-Zhi Liao, Yu-Hsuan Chen, Jyh-Nong Tsai, et al.
ACS Medicinal Chemistry Letters
|
April 20, 2018
Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers
Janeta Popovici-Muller, René M Lemieux, Erin Artin, et al.
Journal of Medicinal Chemistry
|
December 4, 2024
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid Cancers
Christopher L Carroll, Michael G Johnson, Yanbing Ding, et al.
Phytopathology
|
May 28, 2025
Opportunities and Challenges in Combining Optical Sensing and Epidemiological Modeling
Alexey Mikaberidze, C D Cruz, Ayalsew Zerihun, et al.
Cancer Discovery
|
February 15, 2017
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
Katharine Yen, Jeremy Travins, Fang Wang, et al.
Page
of 160
Search research articles
Search
Showing results (1581-1590 of 1,594) with videos related to
Sort By:
Page
of 160
Cancer Medicine
|
July 12, 2019
Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms
Yu Zhang, Liang Shang, Pan-Pan Zhang, et al.
Journal of Medicinal Chemistry
|
April 8, 2021
Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous <i>MTAP</i> Deletion
Zenon Konteatis, Jeremy Travins, Stefan Gross, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma
Zenon Konteatis, Erin Artin, Brandon Nicolay, et al.
Annals of Human Genetics
|
March 2, 2019
Significant association of rare variant p.Gly8Ser in cardiac sodium channel β4-subunit SCN4B with atrial fibrillation
Hongbo Xiong, Qin Yang, Xiaoping Zhang, et al.
Chemistry & Biology
|
September 25, 2012
Small molecule activation of PKM2 in cancer cells induces serine auxotrophy
Charles Kung, Jeff Hixon, Sung Choe, et al.
Plant Disease
|
November 26, 2022
Translocation of Fungicides and Their Efficacy in Controlling <i>Phellinus noxius</i>, the Cause of Brown Root Rot Disease
Ting-Zhi Liao, Yu-Hsuan Chen, Jyh-Nong Tsai, et al.
ACS Medicinal Chemistry Letters
|
April 20, 2018
Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers
Janeta Popovici-Muller, René M Lemieux, Erin Artin, et al.
Journal of Medicinal Chemistry
|
December 4, 2024
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid Cancers
Christopher L Carroll, Michael G Johnson, Yanbing Ding, et al.
Phytopathology
|
May 28, 2025
Opportunities and Challenges in Combining Optical Sensing and Epidemiological Modeling
Alexey Mikaberidze, C D Cruz, Ayalsew Zerihun, et al.
Cancer Discovery
|
February 15, 2017
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
Katharine Yen, Jeremy Travins, Fang Wang, et al.
Page
of 160